|
시장보고서
상품코드
2050933
융합 생검 시장 : 생검 경로별, 제품별, 용도별, 최종사용자별, 지역별Fusion Biopsy Market, By Biopsy Route, By Product, By Application, By End User, By Geography |
||||||
융합 생검 시장은 2026년에 8억 6,150만 달러로 추정되고, 2033년까지 15억 6,480만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 8.9%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 8억 6,150만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 8.90% | 2033년 시장 규모 예측 : | 15억 6,480만 달러 |
융합 생검은 자기공명영상(MRI)과 초음파라는 두 가지 의료 영상 기술을 결합하여 생검 시술 시 정확도를 높인 실시간 영상 가이던스를 제공합니다. 이를 통해 의사는 신체 내 의심스러운 조직을 식별하고, 샘플링 오류나 병변을 간과할 위험을 최소화하면서 조직 샘플을 채취할 수 있습니다. 전 세계적으로 전립선암, 폐암, 유방암의 발병률이 증가함에 따라 융합 생검과 같은 첨단 생검 기술에 대한 수요가 전 세계적으로 증가하고 있습니다. 고령 인구 증가, 암 조기 진단에 대한 인식 증가, 의료 영상 시스템의 기술 발전, 개발도상국의 의료비 증가 등의 요인이 예측 기간 동안 시장 성장을 견인할 것으로 예측됩니다.
시장 역학
세계 융합 생검 시장은 암 유병률 증가, 최소 침습 수술에 대한 선호도 증가, 정확한 조직 채취 기술에 대한 수요 증가로 인해 성장하고 있습니다. 세계보건기구(WHO)에 따르면, 향후 20년간 전 세계 암으로 인한 부담은 70% 이상 증가할 것으로 예측됩니다. 융합 생검은 샘플링 오류의 가능성을 최소화하면서 암을 조기에 발견하는 데 도움이 됩니다. 이것이 전 세계 도입을 촉진하고 있습니다. 그러나 융합 생검 기기의 높은 도입 및 유지비용이 시장 성장을 저해하는 요인으로 작용하고 있습니다. 신흥 시장에서의 지역적 입지 확대, 저렴한 가격대의 기기 출시, 종량제 비즈니스 모델 제공 등 시장 진출기업에게 기회가 될 수 있습니다. 인공지능, 로봇 공학, 3D 영상 기술과 통합된 첨단 기기의 승인 및 출시 증가는 향후 몇 년 동안 새로운 기회를 가져올 것입니다. 예를 들어, 2022년에는 의료기기 제조업체인 CMR Surgical사가 연부조직 수술용 로봇 시스템 'Versius'에 대해 미국 FDA로부터 획기적인 의료기기(Breakthrough Device) 지정을 받았습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계 융합 생검 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 모델 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 융합 생검 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 융합 생검 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 융합 생검 시장 : 생검 경로별, 2021년-2033년
제5장 세계의 융합 생검 시장 : 제품별, 2021년-2033년
제6장 세계의 융합 생검 시장 : 용도별, 2021년-2033년
제7장 세계의 융합 생검 시장 : 최종사용자별, 2021년-2033년
제8장 세계의 융합 생검 시장 : 지역별, 2021년-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고 문헌 및 조사 방법
LSH 26.06.15Fusion Biopsy Market is estimated to be valued at USD 861.5 Mn in 2026 and is expected to reach USD 1,564.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 861.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.90% | 2033 Value Projection: | USD 1,564.8 Mn |
Fusion biopsy combines two medical imaging technologies, magnetic resonance imaging (MRI), and ultrasound, to provide real-time image guidance for biopsy procedures with improved accuracy. It helps physicians locate suspicious tissue in the body and obtain tissue samples with minimal risk of sampling error or missing lesions. With rising cases of prostate, lung, and breast cancer worldwide, the demand for advanced biopsy techniques like fusion biopsy is increasing globally. Factors such as growing geriatric population, increasing awareness about early cancer diagnosis, technological advancements in medical imaging systems, and rising healthcare expenditure in developing countries are expected to drive the market growth during the forecast period.
Market Dynamics
The global fusion biopsy market is driven by the rising prevalence of cancer, increasing preference for minimally invasive surgeries, and growing need for accurate tissue sampling techniques. According to WHO, cancer burden is expected to rise by over 70% in the next 20 years worldwide. Fusion biopsy aids in detecting cancers at an early stage with minimal chances of sampling errors. This is propelling its adoption globally. However, high installation and maintenance costs of fusion biopsy devices is restraining market growth. Opportunities for market players lie in expanding their regional presence in emerging markets, launching affordable devices and offering pay-per-use business models. Increasing approvals and launch of advanced devices integrated with artificial intelligence, robotics and 3D imaging technologies will also offer new opportunities in coming years. For example, in 2022, CMR Surgical, a medical equipment manufacturer, received breakthrough device designation from the U.S. FDA for its Versius surgical robotic system for soft tissue procedures.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global fusion biopsy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include GE Healthcare, Koninklijke Philips N.V., FUJIFILM Corporation, Siemens Healthineers, Hitachi, Ltd., Canon Medical Systems Corporation, Medtronic, Hologic, Inc., Varian Medical Systems, Boston Scientific Corporation, Becton, Dickinson and Company, Agilent Technologies, Inc., 3M Company, Carestream Health, and Neusoft Medical Systems Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global fusion biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fusion biopsy market.
Market Segmentation
- Biopsy Route Insights (Revenue, USD Mn, 2021 - 2033)
- Transrectal
- Transperineal
- Product Insights (Revenue, USD Mn, 2021 - 2033)
- Equipment
- MRI machines
- Ultrasound devices
- Fusion biopsy systems
- Others
- Consumables
- Biopsy needles
- Imaging contrast agents
- Others
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Prostate Cancer
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Diagnostic Centers
- Ambulatory Care Centers
- Academic & Research Laboratories
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- GE Healthcare
- Koninklijke Philips N.V.
- FUJIFILM Corporation
- Siemens Healthineers
- Hitachi, Ltd.
- Canon Medical Systems Corporation
- Medtronic
- Hologic, Inc.
- Varian Medical Systems
- Boston Scientific Corporation
- Becton, Dickinson and Company
- Agilent Technologies, Inc.
- 3M Company
- Carestream Health
- Neusoft Medical Systems Co., Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Fusion Biopsy Market, By Biopsy Route
- Global Fusion Biopsy Market, By Product
- Global Fusion Biopsy Market, By Application
- Global Fusion Biopsy Market, By End User
- Global Fusion Biopsy Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Fusion Biopsy Market, By Biopsy Route, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Transrectal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Transperineal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
5. Global Fusion Biopsy Market, By Product, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- MRI machines
- Ultrasound devices
- Fusion biopsy systems
- Others
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Biopsy needles
- Imaging contrast agents
- Others
6. Global Fusion Biopsy Market, By Application, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
7. Global Fusion Biopsy Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Ambulatory Care Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Academic & Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
8. Global Fusion Biopsy Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Biopsy Route, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Biopsy Route, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Biopsy Route, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Biopsy Route, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Biopsy Route, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Biopsy Route, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- FUJIFILM Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hitachi, Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Varian Medical Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 3M Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Carestream Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Neusoft Medical Systems Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
